Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
24.99
-0.37 (-1.46%)
At close: Apr 2, 2026, 4:00 PM EDT
25.00
+0.01 (0.04%)
After-hours: Apr 2, 2026, 6:40 PM EDT
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Eton Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $39.33, which forecasts a 57.38% increase in the stock price over the next year. The lowest target is $31 and the highest is $52.
Price Target: $39.33 (+57.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $26 → $31 | Strong Buy | Maintains | $26 → $31 | +24.05% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $52 | Strong Buy | Maintains | $37 → $52 | +108.08% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +40.06% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $29 → $30 | Strong Buy | Maintains | $29 → $30 | +20.05% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | +48.06% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
112.65M
from 79.95M
Increased by 40.90%
Revenue Next Year
165.85M
from 112.65M
Increased by 47.23%
EPS This Year
0.92
from -0.17
EPS Next Year
1.53
from 0.92
Increased by 65.68%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 116.4M | 185.3M | |||
| Avg | 112.7M | 165.9M | |||
| Low | 107.6M | 148.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 45.6% | 64.5% | |||
| Avg | 40.9% | 47.2% | |||
| Low | 34.6% | 31.5% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 1.23 | 2.00 |
| Avg | 0.92 | 1.53 |
| Low | 0.67 | 1.10 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | 116.5% |
| Avg | - | 65.7% |
| Low | - | 19.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.